Michael L Barnett1,2, Xinhua Zhao3, Michael J Fine3,4, Carolyn T Thorpe3,5, Florentina E Sileanu3, John P Cashy3, Maria K Mor3,6, Thomas R Radomski3,4, Leslie R M Hausmann3,4, Chester B Good3,4,7, Walid F Gellad8,9. 1. Department of Health Policy and Management, Harvard T.H. Chan School of Public Health, Boston, MA, USA. 2. Division of General Internal Medicine and Primary Care, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA. 3. Center for Health Equity Research and Promotion (CHERP), VA Pittsburgh Healthcare System, University Drive, Pittsburgh, PA, USA. 4. Department of Medicine, Division of General Internal Medicine, University of Pittsburgh, Pittsburgh, PA, USA. 5. Division of Pharmaceutical Outcomes and Policy, University of North Carolina Eshelman School of Pharmacy, Chapel Hill, NC, USA. 6. Department of Biostatistics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA. 7. Center for High Value Health Care, University of Pittsburgh Medical Center (UPMC), Pittsburgh, PA, USA. 8. Center for Health Equity Research and Promotion (CHERP), VA Pittsburgh Healthcare System, University Drive, Pittsburgh, PA, USA. walid.gellad@va.gov. 9. Department of Medicine, Division of General Internal Medicine, University of Pittsburgh, Pittsburgh, PA, USA. walid.gellad@va.gov.
Abstract
BACKGROUND: Treatment by high-opioid prescribing physicians in the emergency department (ED) is associated with higher rates of long-term opioid use among Medicare beneficiaries. However, it is unclear if this result is true in other high-risk populations such as Veterans. OBJECTIVE: To estimate the effect of exposure to high-opioid prescribing physicians on long-term opioid use for opioid-naïve Veterans. DESIGN: Observational study using Veterans Health Administration (VA) encounter and prescription data. SETTING AND PARTICIPANTS: Veterans with an index ED visit at any VA facility in 2012 and without opioid prescriptions in the prior 6 months in the VA system ("opioid naïve"). MEASUREMENTS: We assigned patients to emergency physicians and categorized physicians into within-hospital quartiles based on their opioid prescribing rates. Our primary outcome was long-term opioid use, defined as 6 months of days supplied in the 12 months subsequent to the ED visit. We compared rates of long-term opioid use among patients treated by high versus low quartile prescribers, adjusting for patient demographic, clinical characteristics, and ED diagnoses. RESULTS: We identified 57,738 and 86,393 opioid-naïve Veterans managed by 362 and 440 low and high quartile prescribers, respectively. Patient characteristics were similar across groups. ED opioid prescribing rates varied more than threefold between the low and high quartile prescribers within hospitals (6.4% vs. 20.8%, p < 0.001). The frequency of long-term opioid use was higher among Veterans treated by high versus low quartile prescribers, though above the threshold for statistical significance (1.39% vs. 1.26%; adjusted OR 1.11, 95% CI 0.997-1.24, p = 0.056). In subgroup analyses, there were significant associations for patients with back pain (adjusted OR 1.25, 95% CI 1.01-1.55, p = 0.04) and for those with a history of depression (adjusted OR 1.28, 95% CI 1.08-1.51, p = 0.004). CONCLUSIONS: ED physician opioid prescribing varied by over 300% within facility, with a statistically non-significant increased rate of long-term use among opioid-naïve Veterans exposed to the highest intensity prescribers.
BACKGROUND: Treatment by high-opioid prescribing physicians in the emergency department (ED) is associated with higher rates of long-term opioid use among Medicare beneficiaries. However, it is unclear if this result is true in other high-risk populations such as Veterans. OBJECTIVE: To estimate the effect of exposure to high-opioid prescribing physicians on long-term opioid use for opioid-naïve Veterans. DESIGN: Observational study using Veterans Health Administration (VA) encounter and prescription data. SETTING AND PARTICIPANTS: Veterans with an index ED visit at any VA facility in 2012 and without opioid prescriptions in the prior 6 months in the VA system ("opioid naïve"). MEASUREMENTS: We assigned patients to emergency physicians and categorized physicians into within-hospital quartiles based on their opioid prescribing rates. Our primary outcome was long-term opioid use, defined as 6 months of days supplied in the 12 months subsequent to the ED visit. We compared rates of long-term opioid use among patients treated by high versus low quartile prescribers, adjusting for patient demographic, clinical characteristics, and ED diagnoses. RESULTS: We identified 57,738 and 86,393 opioid-naïve Veterans managed by 362 and 440 low and high quartile prescribers, respectively. Patient characteristics were similar across groups. ED opioid prescribing rates varied more than threefold between the low and high quartile prescribers within hospitals (6.4% vs. 20.8%, p < 0.001). The frequency of long-term opioid use was higher among Veterans treated by high versus low quartile prescribers, though above the threshold for statistical significance (1.39% vs. 1.26%; adjusted OR 1.11, 95% CI 0.997-1.24, p = 0.056). In subgroup analyses, there were significant associations for patients with back pain (adjusted OR 1.25, 95% CI 1.01-1.55, p = 0.04) and for those with a history of depression (adjusted OR 1.28, 95% CI 1.08-1.51, p = 0.004). CONCLUSIONS: ED physician opioid prescribing varied by over 300% within facility, with a statistically non-significant increased rate of long-term use among opioid-naïve Veterans exposed to the highest intensity prescribers.
Authors: Melissa J Azur; Elizabeth A Stuart; Constantine Frangakis; Philip J Leaf Journal: Int J Methods Psychiatr Res Date: 2011-03 Impact factor: 4.035
Authors: Mark D Sullivan; Mark J Edlund; Ming-Yu Fan; Andrea DeVries; Jennifer Brennan Braden; Bradley C Martin Journal: Pain Date: 2010-06-15 Impact factor: 6.961
Authors: Joseph A Boscarino; Margaret Rukstalis; Stuart N Hoffman; John J Han; Porat M Erlich; Glenn S Gerhard; Walter F Stewart Journal: Addiction Date: 2010-08-16 Impact factor: 6.526
Authors: Adi V Gundlapalli; Audrey L Jones; Andrew Redd; Ying Suo; Warren B P Pettey; April Mohanty; Emily Brignone; Lori Gawron; Megan Vanneman; Matthew H Samore; Jamison D Fargo Journal: Stud Health Technol Inform Date: 2017
Authors: Benjamin W Friedman; Andrew A Dym; Michelle Davitt; Lynne Holden; Clemencia Solorzano; David Esses; Polly E Bijur; E John Gallagher Journal: JAMA Date: 2015-10-20 Impact factor: 56.272
Authors: Tej D Azad; Yi Zhang; Martin N Stienen; Daniel Vail; Jason P Bentley; Allen L Ho; Paras Fatemi; Daniel Herrick; Lily H Kim; Austin Feng; Kunal Varshneya; Michael Jin; Anand Veeravagu; Jayanta Bhattacharya; Manisha Desai; Anna Lembke; John K Ratliff Journal: J Gen Intern Med Date: 2019-11-12 Impact factor: 5.128
Authors: Iraklis E Tseregounis; Daniel J Tancredi; Susan L Stewart; Aaron B Shev; Andrew Crawford; James J Gasper; Garen Wintemute; Brandon D L Marshall; Magdalena Cerdá; Stephen G Henry Journal: Med Care Date: 2021-12-01 Impact factor: 2.983
Authors: Stephen G Henry; Susan L Stewart; Eryn Murphy; Iraklis Erik Tseregounis; Andrew J Crawford; Aaron B Shev; James J Gasper; Daniel J Tancredi; Magdalena Cerdá; Brandon D L Marshall; Garen J Wintemute Journal: J Gen Intern Med Date: 2021-03-19 Impact factor: 5.128